Treatment of stage IIIB squamous-cell lung cancer with pembrolizumab combined with chemotherapy to achieve pCR: a case reportFanghao Liu, Guoli Lv, Yunfeng Miao et al.|Blood and Genomics|2021Cited by 0
Characterization of clinical risk factors for enhanced molecular residual disease monitoring in resected early-stage non-small cell lung cancerYunfei Shi, Jin Duan, Youming Lei et al.|BMC Cancer|2025Cited by 0